LNCaP clone FGC Cells

The LNCaP clone FGC (Fast Growing Colonies) is an epithelial cell line that has become a cornerstone in the field of cancer research, especially in studies related to prostate cancer. The parent LNCaP cell line was established from a metastatic carcinoma of the prostate in a 50-year-old Caucasian male patient originating from a needle aspiration biopsy of the left supraclavicular lymph node. These human prostate carcinoma cells demonstrate notable tumorigenic properties in soft agar and nude mice, underlining its relevance in studying the invasive and metastatic aspects of cancer. The LNCaP clone FGC is characterized by its adherent growth pattern, often forming single cells and loosely attached clusters, its slow growth rate and a propensity to rapidly acidify the culture medium. A defining feature of the LNCaP clone FGC is its expression of key prostate cancer markers such as human prostatic acid phosphatase and prostate-specific antigen (PSA), with a strong androgen sensitivity. This sensitivity to androgens and the involvement of the androgen receptor axis in the regulation of proliferation make the prostatic cancer cell line LNCaP clone FGC an invaluable in vitro model for the study of androgen sensitivity and its implications in prostate carcinogenesis. In summary, the human prostate cancer cell line LNCaP clone FGC, with its unique characteristics and extensive utility in advanced cancer research applications, including 3D cell culture and transfection studies, continues to be highly cited and valued in the field of human cell research, providing deep insights into the molecular and cellular mechanisms underpinning prostate cancer and offering avenues for the development of novel therapeutic strategies.